Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Endocrinol (Oxf) ; 80(3): 459-63, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23895145

RESUMEN

OBJECTIVE: Postoperative radioiodine remnant ablation (RRA) represents an adjunctive therapeutic modality in patients with differentiated thyroid cancer (DTC). The impact of late vs early RRA on the outcome of DTC is currently unclear. The aim of the study was to evaluate the outcome of patients with DTC according to RRA timing. DESIGN RETROSPECTIVE STUDY PATIENTS: A total of 107 TNM stage 1 DTC patients were divided into two groups. In group A (n = 50), RRA was administered in less than 4·7 months median 3·0 (range 0·8-4·7), while in group B (n = 57) in more than 4·7 months median 6 (4·8-30·3) after thyroidectomy. Remission was achieved when stimulated serum Tg levels were undetectable, in the absence of local recurrence or cervical lymph node metastases on the neck ultrasound. RESULTS: All patients underwent near-total thyroidectomy. The mean age at diagnosis was 49·3 years (range: 18-79 years). There were no statistically significant differences in the histological subtype, the TNM stage, the dose of radioiodine and the time of follow-up, between the two groups. After the RRA treatment, 44 group A patients (88%) were in remission and 6 (12%) in persistence; while in group B, 52 (91·2%) were in remission, 1 (1·8%) in persistence and 4 (7%) in recurrence. At their latest follow-up median 87·3 (23·3-251·6 months), all patients were in remission, either as a result of further iodine radioiodine therapy (in 11 patients) or watchful monitoring. CONCLUSIONS: The timing of RRA seems to have no effect on the long-term outcome of the disease. Therefore, urgency for radioiodine ablation in patients with low-risk thyroid cancer is not recommended.


Asunto(s)
Carcinoma Papilar Folicular/radioterapia , Carcinoma Papilar Folicular/cirugía , Radioisótopos de Yodo/uso terapéutico , Neoplasias de la Tiroides/radioterapia , Neoplasias de la Tiroides/cirugía , Adolescente , Adulto , Anciano , Carcinoma Papilar Folicular/epidemiología , Carcinoma Papilar Folicular/patología , Terapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasia Residual , Periodo Posoperatorio , Radioterapia Adyuvante , Estudios Retrospectivos , Neoplasias de la Tiroides/epidemiología , Neoplasias de la Tiroides/patología , Tiroidectomía , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
2.
Hellenic J Cardiol ; 49(6): 441-5, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19110933

RESUMEN

The simultaneous occurrence of atrial and ventricular tachycardias, or junctional and ventricular tachycardias, has been reported previously. We report on a patient presenting with syncope and demonstrating, simultaneously, atrioventricular re-entrant tachycardia and ventricular tachycardia of left origin. A left lateral concealed pathway was responsible for the former arrhythmia, while the latter arrhythmia was located in the anterolateral wall of the left ventricle. This is a rare type of double tachycardia and stresses the need for a thorough investigation of patients who have concealed accessory pathways and a previous history of atrioventricular re-entrant tachycardia, when they present with syncope.


Asunto(s)
Taquicardia por Reentrada en el Nodo Atrioventricular/epidemiología , Taquicardia Ventricular/epidemiología , Anciano , Comorbilidad , Electrocardiografía , Técnicas Electrofisiológicas Cardíacas , Sistema de Conducción Cardíaco/anomalías , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA